This study highlights that T cells-promote tumor ferroptosis and that targeting this pathway (xCT-GSH/GPX) in combination with anti-PD-1 or anti-PD-L1 antibodies could be a useful strategy (Table 2). Here, PDCD1 is linked to neoplasm.